CD27 and B-cell chronic lymphocytic leukemia: The analysis of B-cell subpopulations found an increase in the levels of plasmablasts (CD27++CD20-CD21low) in healthy donors and W&W participants throughout the study, in contrast to treated CLL participants which presented only a slight increase in Sample 1 (Figure 2A).